Nester, C., Appel, G. B., Bomback, A. S., Bouman, K. P., Cook, H. T., Daina, E., Dixon, B. P., Rice, K., Najafian, N., Hui, J., Podos, S. D., Langman, C. B., Lightstone, L., Parikh, S. V., Pickering, M. C., Sperati, C. J., Trachtman, H., Tumlin, J., de Vries, A. P., … Remuzzi, G. (2022). Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies. American Journal of Nephrology, 53(10), 687–700. Portico. https://doi.org/10.1159/000527167
Columbia Affiliation:
Subjects:
Pathophysiology of Glomerular Diseases and Nephrotic Syndromes
(OpenAlex Topic)
Role of Complement System in Immune Response
(OpenAlex Topic)
Hereditary Angioedema: Molecular Mechanisms and Clinical Management
(OpenAlex Topic)
Kidney Diseases
(MeSH)
Publication Type:
Article
Unique ID:
10.1159/000527167
PMID:
DOI:
Journal:
Publication Date:
Data Source:
Scopus